InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: thesisthink post# 30179

Tuesday, 11/10/2020 4:20:42 PM

Tuesday, November 10, 2020 4:20:42 PM

Post# of 44690
My recent post's points were a 50% differential in the rating of patients recovery after treatment would be monumental compared to the current rates of success.
Big-Pharma is focusing on virs/mAbs/*vaccines.
At the recent NIH videocast, the FDA rep stressed their job to regulate and Not bend rules.
Repurposed drugs may make it to market sooner than others due to good past Safety records.
There is a huge market for Prevention and treatments of COVID and then the recovery from the resulting damages...GLTA...